Clinical Trial Update: Long-term Result of DTPA (Diethylenetriamine Pentaacetate) Chelation for Gadolinium Deposition Disease

View source ↗

Summary

An update on a clinical trial evaluating long-term DTPA chelation therapy for gadolinium deposition disease; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gadolinium Deposition Disease

Drugs mentioned

• Ca-DTPA (calcium trisodium diethylenetriaminepentaacetate)

Snippet

Sponsor: Stanford University | Conditions: Gadolinium Deposition Disease, Ca-DTPA | Status: RECRUITING